Pryor, Cardin Call for Increased Research to Ensure Product Safety
Summary posted by Meridian on 1/26/2010
Source: Mark Pryor, United States Senator
Author: n/a
United States Senators Mark Pryor (D-AR) and Benjamin L. Cardin (D-MD) last week introduced legislation designed to address the potential health and safety risks of products containing nanotechnology materials. The legislation, The Nanotechnology Safety Act of 2010, would establish a program within the U.S. Food and Drug Administration (FDA), with funding of US$25 million per year from 2011 through 2015, to assess the health and safety implications of nanotechnology in consumer products and develop best management practices for companies using nanotechnology. According to Senator Pryor, "[N]anotechnology is one of the most important and enabling technologies being developed right now, and it has hundreds of promising applications – from new cancer treatments to improved military machinery to stain-resistant pants. As these products are developed and used, we must understand any potential risks to human health, safety or the environment. My legislation will help ensure public safety and confidence in the marketplace, and it will support companies that employ nanotechnology materials." The article can be viewed online at the link below.
The original article may still be available at pryor.senate.gov/public/index.cfm?p=PressReleases&ContentRecord_id=...
As tagged by Meridian Institute:
Implications:
Human Enhancement, Human Health Risks, Worker Safety, Governance, Environmental Risks, Economic Competitiveness
Nanomaterials:
Carbon Nanoparticle, Metal Nanoparticle, Naturally Occurring
Regions:
North America
Stakeholders:
Government, Industry
Related Forums:
3rd International Seminar on Nanosciences and Nanotechnology
-- Seminario Naotecnologias Cuba (7/29/2010) The 3rd International Seminar on Nanosciences and Nanotechnology, organized by the Office of the Scientific Advisor to the State Council of the Republic of Cuba and the Center for Advanced Cuban Studes (CEAC), will take place from September 6-10, 2010, in Havana, Cuba. The aim of the conference is to open new paths of cooperation for the development of CEAC, consolidate existent and emerging networks in the country, and provide elements for the design of a national strategy in this field. [More]
Super-sizing a Cancer Drug Minimizes Side Effects
-- MIT News (7/29/2010) Scientists at the Harvard-MIT Division of Health Sciences and Technology (HST) have designed a new version of the drug cisplatin, one of the first chemotherapy drugs given to patients diagnosed with cancer, that spares the kidneys, allowing doctors to use higher doses. [More]
An Asphalt Pact Cut Fumes—& Created A Model
-- New Haven Independent (7/29/2010) At a recent conference hosted by the United States National Institute for Occupational Safety and Health (NIOSH), convened to talk about the potential health hazards in the nanotechnology industry, a successful partnership between government, industry, and workers to tackle worker safety in the asphalt industry was looked to as a possible model for addressing worker safety in the nanotechnology industry. [More]
Nanomagnets Remove Pathogens from Blood
-- Nanowerk (7/28/2010) Researchers from the Institute for Chemical and Bioengineering of the ETH Zurich, Switzerland, have demonstrated a novel use of nanomagnets to rapidly and selectively remove heavy metal ions, overdosed steroid drugs and proteins from human blood. [More]
Learn how to include these headlines on your own website by clicking here.
Please email us if you require text-only versions of the daily emails.
